Prions represent an unusual structural form of a protein that is 'infectious'. In mammals, prions are associated with fatal neurodegenerative diseases such as CJD (Creutzfeldt-Jakob disease), while in fungi they act as novel epigenetic regulators of phenotype. Even though most of the human prion diseases arise spontaneously, we still know remarkably little about how infectious prions form de novo. 
Introduction
To explain why the causative agent of sheep scrapie was resistant to treatments that inactivate nucleic acids, such as UV radiation and formaldehyde, Griffith [1] invoked the presence of an infectious protein. This idea was further elaborated on by Prusiner and co-workers, who introduced the term prion, a 'small proteinaceous infectious particle which resists inactivation by procedures that modify nucleic acids' [2, 3] . The prion protein in scrapie and related diseases in other mammals [e.g. bovine spongiform encephalopathy and human CJD (Creutzfeldt-Jakob disease)] is designated PrP: while PrP c denotes the normal soluble form, PrP Sc denotes the infectious 'scrapie' form. In 1994, Prusiner's 'proteinonly' prion hypothesis was proposed by Reed Wickner to account for the unusual genetic behaviour of [URE3], a non-Mendelian trait of yeast Saccharomyces cerevisiae that modified the ability of cells to utilize poor nitrogen sources [4] . Subsequently, several other fungal prions have been described and their unusual properties validated experimentally, namely [ Mammalian prion diseases such as CJD either can arise de novo (i.e. sporadic form) or can result from infection (i.e. acquired form) or can result from the inheritance of a mutant allele of the PrP gene (i.e. familial form), which leads to a destabilization of the structure of PrP. The most predominant form of CJD is the sporadic form, which accounts for over 80% of the verified cases of CJD in the U.K. (National Creutzfeldt-Jakob Disease Surveillance Unit; http://www. cjd.ed.ac.uk). For PrP Sc to form de novo, it is assumed that the natively folded protein adopts an alternative conformational state, either by spontaneously misfolding or as a consequence of an interaction with other cellular factors, leading to the formation of the PrP Sc 'isoform' that can act as a template for the conversion of PrP c molecules into the infectious PrP Sc conformer. While soluble forms of PrP and the various fungal prion proteins can spontaneously polymerize to form amyloid fibrils in vitro in the absence of added cellular factors, the mechanism of de novo formation in vivo is poorly understood in molecular terms. A recent study has suggested that the formation of a PrP dimer is sufficient to trigger de novo formation of PrP Sc [7] . Alternatively, several molecules of the misfolded protein may spontaneously form a catalytically active oligomer, as has been suggested for the yeast [PSI + ] prion [8] . Yeast prions can form de novo in the absence of transmission of pre-existing prion seeds (propagons) from another cell, but the frequency of such a spontaneous appearance is of the order of 1 in 10 5 (i.e. 10 −5 ). This frequency can be elevated by several orders of magnitude by overexpression of the corresponding prion protein [4, 9] . As with de novo PrP Sc formation, the assumption is that spontaneous formation of yeast prions arises as a consequence of a random protein misfolding event, an event whose occurrence is greatly elevated when the protein folding machinery is swamped by excess of the protein or impaired by mutation. Yet, as has become clear from studies we review below, the level of spontaneous formation of a yeast prion is regulated by both cellular and epigenetic factors. [11, 12] . Sup35p [also known as eRF3 (eukaryotic release factor 3)] facilitates translation termination through its interaction with Sup45p (eRF1), leading to polypeptide chain release [13, 14] .
The prion-like behaviour of Sup35p is controlled by its Nterminal region, which is also called the PrD (prion-forming domain), whereas its C-terminal region is necessary and sufficient for its role in translation termination [15] . The Nterminal and C-terminal regions of Sup35p are separated by the charged M region that is dispensable for translation termination [15, 16] but may contribute to the prion properties of the protein [17] [18, 19] .
The efficiency with which [PSI + ] (and other yeast prions) is maintained in growing cells lies in the action of the molecular chaperone Hsp104 (heat-shock protein 104) [20] . New prion seeds (propagons) are thought to be generated by the disaggregation of the Sup35p prion polymers that continually form in [PSI + ] cells. Such a disaggregation is mediated by the action of Hsp104 in conjunction with other chaperones of the Hsp70 (Ssa/Ssb) and Hsp40 (Ydj1p, Sis1p) families (see [21] for a review). High-frequency loss of [PSI + ] from growing cells can result from inhibiting the activity of Hsp104 using millimolar concentrations of GdmCl (guanidinium chloride) [22, 23] or by overexpression of 
Other factors influencing the de novo formation of [PSI + ]
A variety of proteins, other than those that have been proved to form prions, can also influence the de novo formation of [PSI + ]. These include Sup45p, the native binding partner of Sup35p, members of the Hsp70 chaperone family and components of the UPS (ubiquitin-proteasome system) ( Table 2 ).
Sup45p (eRF1)
Sup45p physically and functionally interacts with Sup35p to form a release factor complex essential for translation termination [13, 14] . Sup35p interacts with the C-terminus of Sup45p [34] , and any Sup35p molecule that has formed a complex with Sup45p is presumably not available for de novo conversion. Consistent with this hypothesis, Derkatch et al. [35] found that overexpression of the SUP45 gene significantly reduced the frequency of induced de novo formation of [ 
Chaperones
Molecular chaperones play a central role in the co-and posttranslational folding of polypeptides and would therefore be expected to act as key cellular regulators of de novo prion formation in addition to their role in prion propagation [21] . Although chaperones from the Hsp104, Hsp70 and Hsp40 families contribute to the mechanism of yeast prion propagation [21] [36] . These effects suggest that the Ssa chaperones might stabilize the 'misfolded' conformations of prion proteins and in so doing facilitate their conversion [37] . The closely related Ssbs might function to remove or refold the critical misfolded conformers that form. The fundamental differences in the way Ssa and Ssb chaperones deal with such misfolded conformers can be attributed to their distinct peptide-binding domains [37] .
Factors that affect Ssa/Ssb synthesis and/or function also affect the frequency of de novo prion formation. For example, elevations in the levels of Sse1p (a nucleotide-exchange factor for Hsp70) promotes de novo formation, while a SSE1 strain shows a reduced frequency of appearance of [PSI + ] [38] . Mutational changes to the HSF (heat-shock factor; encoded by the HSF1 gene) also affect de novo formation [39] , presumably by modulating the transcription of the various Hsp70/Hsp110-encoding genes.
While a number of studies have demonstrated a role for chaperones in the formation and propagation of [PSI + ], none have yet identified the molecular species that chaperones interact with. In vitro formation of mature amyloid fibrils of Sup35p molecules is preceded by aggregation of these molecules into oligomeric species [8] , and it is possible that rather than binding monomers of Sup35p, the Ssa/Ssb chaperones may interact with such oligomers, if they form in vivo. . However, as there is no evidence that Sup35p is ubiquitinated, this effect might be indirect, possibly by triggering the formation of large aggresome-like structures [42] .
In conclusion, a number of cellular factors can modulate the frequency with which yeast prions form de novo. While these factors exist primarily to deal with misfolded and potentially toxic conformers in both stressed and non-stressed cells, they can also modulate the formation of novel epigenetic elements, one of which, namely the [PSI + ] prion, has an effect on the ability of the yeast cell to combat a variety of environmental abuses [43, 44] .
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